Enhance: A multi-centre, randomised phase IV study
Project Details
Introduction: This collaborative study compares newer formulations of oxycodone across different settings for people with cancer
Title - Enhance: A multi-centre, randomised, phase IV study to compare the efficacy of oxycodone/naloxone verses oxycodone prolonged release tablets in patients with advanced cancer
Key Aim To evaluate two pain relief medications, oxycodone/naloxone prolonged-release (OXN PR) and oxycodone alone prolonged-release (Oxy PR) with respect to analgesic efficacy and constipation in patients with advanced cancer.
Further Information: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377673&isReview=true
Researchers
Principal Investigator: Dr Aaron Wong, Peter MacCallum Cancer Centre (Aaron.wong@petermac.org)
Collaborators
Mundipharma
Funding
Mundipharma
Research Group
Faculty Research Themes
School Research Themes
Key Contact
For further information about this research, please contact the research group leader.
Department / Centre
Node
St Vincent's Hospital
MDHS Research library
Explore by researcher, school, project or topic.